No Result
View All Result
  • Login
Thursday, October 30, 2025
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Business

Adaptogens are popular for reducing stress and anxiety. One expert warns of the risks

by FeeOnlyNews.com
5 months ago
in Business
Reading Time: 3 mins read
A A
0
Adaptogens are popular for reducing stress and anxiety. One expert warns of the risks
Share on FacebookShare on TwitterShare on LInkedIn



Finding a way to manage stress and anxiety takes a lot of mental effort, which is why some look to supplements for additional support. And if you’ve ever researched the many different suggestions for stress and anxiety management, you’ve likely come across the term adaptogens. These are ingredients derived from herbs, roots, mushrooms, and plants that are converted into nutritional supplements or added to other foods.

Adaptogen supplements have surged in popularity—the market value was estimated at over $10 billion in 2023 and only expected to grow. Common adaptogen supplements include ashwagandha, rhodiola, and ginseng, which can be found in capsules or teas; and fungi, like the reishi mushroom, which is often dried and crushed into a powder. As adaptogens have become more mainstream, you can even buy in the form of mushroom coffee, sparkling water, and drink mixes.

But do these supplements actually work? Here’s what one expert has to say.

Do adaptogens help relieve stress and anxiety?

Adaptogens “may help our bodies manage stress or more-quickly restore homeostasis (or the body’s natural balance) after stressful situations,” says Dana Hunnes, senior dietitian supervisor at UCLA Medical Center and professor at the Fielding School of Public Health. 

Those stressors can be physiological, like an injury or burnout from work, or psychological, such as from emotional distress, she adds.

Hunnes explains that adaptogens may help lower cortisol levels which would dampen the body’s stress response. But that largely depends on the dose you get, which can be hard to pinpoint.

“It’s not really clear how effective they are and what dose is ‘needed’ to have the desired effect,” Hunnes tells Fortune in an email. 

Ashwagandha, for example, is an herb that’s been used for centuries in India’s Ayurvedic system of medicine. Some research indicates that it may help improve sleep and alleviate anxiety. But how much is needed to benefit is unclear.

“Additionally, it’s not known whether the dose of adaptogens that are available for purchase, or the amounts found in supplements or beverages on the market are high enough to produce a medicinal effect,” Hunnes says.

And since there is little evidence that one type of adaptogen is better than another, Hunnes explains, so it’s hard to say which will work best for you. 

The risks of taking adaptogens

Adaptogens, like other supplements, aren’t regulated the way drugs are—which could lead to a wide variation in dosage. “So what you think you’re buying may not actually contain as much—or may sometimes contain more—than you think,” Hunnes says.

She also cautions that adaptogens carry risks and side effects, which is why you should always talk to your doctor before taking any supplement. Ashwagandha, one of the more popular forms of adaptogens, has been associated with an increased risk of acute liver toxicity or shock and should not be used during pregnancy. Ashwagandha may also increase testosterone levels, which is often not desirable for women.  

Reishi mushroom may produce side effects, like nausea and insomnia, and could cause liver damage, according to Memorial Sloan Kettering Cancer Center.

“Not every ‘herbal supplement’ is good for you or safe to consume,” Hunnes says.

Additionally, there are potential drug interactions that come with any adaptogens, she says. Reishi mushroom could negatively interact with commonly prescribed blood thinners, like warfarin, increasing the risk of bleeding. Taking adaptogens with antidepressants could lead to symptoms like abdominal pain, nausea, and restless leg syndrome. 

“Just because something claims to be healthy in isolation, does not mean it will be healthy in your body or mixed with other medications,” Hunnes says.

Should you take adaptogens?

“I honestly wouldn’t recommend it,” Hunnes says. “There are just too many unknown or unknowable interactions that can take place between taking ‘supplements’ and ‘herbs’ and medications, even over the counter medications.”

“I really would advocate for finding non-medicinal ways of dealing with anxiety or stress,” she adds.

If you find yourself in a period of high stress or anxiety, Hunnes recommends the following strategies before reaching for a supplement:

Slow down and take time for yourself.

Set boundaries.

Do things that relax you.

Spend time in nature.

Cut back on caffeine, which can cause more stimulation.

The American Psychological Association (APA) also has grounding and relaxation techniques to help calm your nervous system. However, if you are struggling with chronic stress and anxiety, the APA advises seeking professional help from a psychologist.

For more on supplements:

Why probiotic supplements might be ‘a waste of money’ and could even backfire for some

The dietary supplements you think are improving your health may be damaging your liver, research warns

The best diet to help lower your risk of prostate cancer, according to experts 

3 takeaways from a cardiologist and ‘SuperAgers’ researcher on how to live longer and healthier 

This story was originally featured on Fortune.com



Source link

Tags: AdaptogensAnxietyExpertPopularReducingRisksstressWarns
ShareTweetShare
Previous Post

Credit default swaps are in demand again amid U.S. fiscal worries

Next Post

Markets shrug off US appeals court’s decision to reinstate Trump tariffs

Related Posts

Michael Saylor’s Strategy returns to profitability in third quarter

Michael Saylor’s Strategy returns to profitability in third quarter

by FeeOnlyNews.com
October 30, 2025
0

Bitcoin accumulator Strategy Inc. returned to profitability in the third quarter, with results bolstered by an unrealized gain tied to...

AI bubble talk grips the market. But in the C-suite there’s more FOMO over AI’s benefits than fear of an AI bustup

AI bubble talk grips the market. But in the C-suite there’s more FOMO over AI’s benefits than fear of an AI bustup

by FeeOnlyNews.com
October 30, 2025
0

Hello and welcome to Eye on AI. In this edition…Nvidia becomes the first $5 trillion market cap company…Anthropic finds AI...

Undiscovered AI Stock Delivers Staggering Returns, Outperforming Tech Titans

Undiscovered AI Stock Delivers Staggering Returns, Outperforming Tech Titans

by FeeOnlyNews.com
October 30, 2025
0

HelloRF Zcool / Shutterstock.com NVIDIA Corp. (NASDAQ:NVDA) continues to remain an industry leader and the most valuable company in the world....

Cleveland-Cliffs names Korea’s Posco as new strategic partner (CLF:NYSE)

Cleveland-Cliffs names Korea’s Posco as new strategic partner (CLF:NYSE)

by FeeOnlyNews.com
October 30, 2025
0

Taitai6769/iStock via Getty ImagesCleveland-Cliffs (CLF) named South Korean steelmaker Posco Holdings (PKX) as its new strategic partner Thursday, identifying the...

The uncomfortable secret of successful people: Forget work-life balance, you have to be ‘obsessed’, ex-Wall Streeter and business coach says

The uncomfortable secret of successful people: Forget work-life balance, you have to be ‘obsessed’, ex-Wall Streeter and business coach says

by FeeOnlyNews.com
October 30, 2025
0

While casual side hustles can sometimes pay off, the most successful people prioritize their passion to turn it into profit. ...

Motilal Oswal Q2 Results: PAT plunges 68% YoY to Rs 362 crore, but posts record operating profit

Motilal Oswal Q2 Results: PAT plunges 68% YoY to Rs 362 crore, but posts record operating profit

by FeeOnlyNews.com
October 30, 2025
0

Motilal Oswal Financial Services Ltd (MOFSL) reported 68% year-on-year (YoY) decline in its consolidated net profit at Rs 362 crore....

Next Post
Markets shrug off US appeals court’s decision to reinstate Trump tariffs

Markets shrug off US appeals court's decision to reinstate Trump tariffs

IndusInd Bank: Sebi bans former IndusInd executives over insider trading allegations

IndusInd Bank: Sebi bans former IndusInd executives over insider trading allegations

  • Trending
  • Comments
  • Latest
AB Infrabuild, among 5 cos to approach record date for stock splits. Last day to buy for eligibility

AB Infrabuild, among 5 cos to approach record date for stock splits. Last day to buy for eligibility

October 15, 2025
Housing Market Loses Steam, “National Buyer’s Market” Likely in 2026

Housing Market Loses Steam, “National Buyer’s Market” Likely in 2026

October 14, 2025
Are You Losing Out Because of Medicare Open Enrollment Mistakes?

Are You Losing Out Because of Medicare Open Enrollment Mistakes?

October 13, 2025
Coinbase boosts investment in India’s CoinDCX, valuing exchange at .45B

Coinbase boosts investment in India’s CoinDCX, valuing exchange at $2.45B

October 15, 2025
Government shutdown could drain financial advisor optimism

Government shutdown could drain financial advisor optimism

October 7, 2025
Getting Started: How to Register

Getting Started: How to Register

October 10, 2025
6 Practical Strategies (For Anyone)

6 Practical Strategies (For Anyone)

0
The Prompting Company snags .5M to help products get mentioned in ChatGPT and other AI apps

The Prompting Company snags $6.5M to help products get mentioned in ChatGPT and other AI apps

0
Insurance Predictions For 2026

Insurance Predictions For 2026

0
Commonwealth advisors leave for Cetera, Osaic, Raymond James

Commonwealth advisors leave for Cetera, Osaic, Raymond James

0
Michael Saylor’s Strategy returns to profitability in third quarter

Michael Saylor’s Strategy returns to profitability in third quarter

0
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

0
Commonwealth advisors leave for Cetera, Osaic, Raymond James

Commonwealth advisors leave for Cetera, Osaic, Raymond James

October 30, 2025
Michael Saylor’s Strategy returns to profitability in third quarter

Michael Saylor’s Strategy returns to profitability in third quarter

October 30, 2025
6 Reasons There Are So Many Tiny Homes For Sale

6 Reasons There Are So Many Tiny Homes For Sale

October 30, 2025
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

October 30, 2025
Market Talk – October 30, 2025

Market Talk – October 30, 2025

October 30, 2025
AI bubble talk grips the market. But in the C-suite there’s more FOMO over AI’s benefits than fear of an AI bustup

AI bubble talk grips the market. But in the C-suite there’s more FOMO over AI’s benefits than fear of an AI bustup

October 30, 2025
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Commonwealth advisors leave for Cetera, Osaic, Raymond James
  • Michael Saylor’s Strategy returns to profitability in third quarter
  • 6 Reasons There Are So Many Tiny Homes For Sale
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.